Acute immune hemolytic reactions are relatively rare but can be life-threatening. The incidence varies depending on the underlying cause:
In the context of blood transfusions, the incidence ranges from 1 in 70,000 to 1 in 100,000 transfusions. In autoimmune conditions like AIHA, the incidence is approximately 1-3 cases per 100,000 people annually.
